EE: Ethinyl estradiol; LNG: Levonorgestrel; OC: Oral contraceptive; RR: Relative risk; VTE: Venous thromboembolism. Transdermal contraceptive patches provide a more convenient delivery system for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

NEW YORK (Reuters Health) - Women who use a contraceptive patch appear to be more than twice as likely to develop a dangerous blood clot in their veins as those who use an oral contraceptive, new ...

Blood clot risk elevated with contraceptive patches, vaginal rings Women who use the combined contraceptive transdermal patch or vaginal ring are at significantly higher risk for venous thrombosis, ...

Astudy published Wednesday in the Journal of the American Medical Association shows women are more likely to use a new birth control patch than the pill. The new birth control patch is supposed to ...

Viatris Inc. (NASDAQ:VTRS) on Thursday, released data from Phase 3 study evaluating the contraceptive efficacy and safety of XULANE LO low dose weekly dermal patch of 150 mcg norelgestromin and 17.5 ...

Xulane (norelgestromin/ethinyl estradiol) is a branded-generic prescription drug used to prevent pregnancy. The drug comes as a transdermal patch you apply to your skin once per week for 3 weeks each ...

WASHINGTON -- Federal health officials approved sale of the world's first contraceptive patch yesterday, giving women an option considered as safe and effective as the pill but easier for some to use.

WASHINGTON, Jan 18 (Reuters) - The label for a Johnson & Johnson contraceptive patch will include new data from a second study showing a higher risk of blood clots compared with birth-control pills, U ...

PITTSBURGH, July 29, 2026 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that the U.S. Food and Drug Administration (FDA) has approved Gwyn Lo™ ...